Microfluidics for Cell Biology
The Advantages of Flow Control for Cell biology and Microscopy
- Shear stress control
- Automation of multiple fluid delivery
- Long term perfusion
What are the advantages of microfluidics in biology?
The development of microfluidics has brought many advantages for biological research. Indeed, due to the miniaturization and the automation of the setups, the consumption of sample and reagent is largely decreased, the experiment times are considerably reduced and the global costs of the applications are minimized. Moreover, working with small quantities allows better carry out separations and detection with high resolution and sensitivity at reduced costs.
Finally, thanks to this new generation of techniques and equipments, new capabilities are offered for biology research since microfluidics allows to obtain more accurate results, to reduce detection limits and even to perform multiple analyses simultaneously.
To learn more about it, feel free to reed our white paper about microfluidic.
Main applications of microfluidics in cell biology

RNA and DNA Hybridization
For decades, in situ hybridization has been used with greater frequency to capture the localization, structure and expression of specific DNA and RNA sequences within tissues. The high sensitivity and specificity of this technique relies on the hybridization of labelled oligonucleotide probes to targeted DNA or RNA sequences within tissues. Chromosomal microdeletion, amplification, structure, translocation and expression can be easily detected.
Compared to PCR analysis, Northern Blotting or a DNA microarray performed on lysed cells, hybridization provides spatial information as specific RNA and DNA are detected within tissues. It has significantly improved gene mapping, cytogenetics and various diagnostic techniques (oncogenic, prenatal, viral infection, etc.).
Recently, with the use of microfluidic for cell biology, a temporal dimension was added to the technology, as it further evolved to be performed on living cells. The spatio-temporal expression, degradation and storage of RNA molecules can now be thoroughly investigated by real time imaging of the hybridization of labelled oligonucleotides in living cells.

Drug Combination and Long-Term Perfusion
In various therapeutic areas (glaucoma, vascular, HIV, oncology), a combination of drugs is typically found to be more effective for disease treatment. Oncology, in particular, has paved the way for this approach. The emergence of next-generation sequencing technology profiling has revealed the heterogeneity in many cancers at the origin of the differential response to treatment. As a result, therapeutic strategies are evolving towards multi-targeted drug combinations that effectively inhibit the cancer cells and block the emergence of drug resistance while selectively incurring minimal side effects on healthy cells.
Drug combination therapy is not straight forward as in many cases the results do not equal the sum of the parts. Cross-reactions are observed and fall into 5 categories: low risk & synergy, low risk & no synergy, caution, unsafe, and dangerous. The contribution and dosage of each active molecule should be closely investigated in terms of dose, frequency and duration to evaluate the efficacy of the drug combination.
Therefore, microfluidics for cell biology holds great promise in cancer diagnosis and also serves as an emerging tool for understanding cancer biology. Microfluidics can be a valuable tool in cancer investigation due to its high sensitivity, high throughput, less material-consumption, low cost, and enhanced spatio-temporal control.

Immunostaining
Immunostaining experiments are mult-istep protocols to detect specific antigens in biological samples. The sample is successively incubated or exposed to fixation agents, washing buffers, and probes.
In conventional protocols on petri dishes or well plates, fluid deliveries are performed manually using pipettes. Solutions are directly added to the sample.
Transferring protocols from a Petri dish to a microfluidic format usually requires some minor adjustments, as cells or tissue samples are exposed to solutions differently. Therefore, the use of microfluidic for cell biology provides many advantages by replacing the use of Petri dishes with microfluidic chambers (closed systems). Consequently, solutions cannot be deposited directly on the top of the cells but are perfused over the sample at a controlled flow rate, reaching all cells homogeneously. The use of a rotary valve with a perfusion system enables one to perfuse different solutions at given time points in the chip or chamber. In addition, automating the sequential delivery of solutions saves time and avoids creating bubbles inside the chips by disconnecting and reconnecting the traditional pump to the chip.
Resources
-
Microfluidics case studies CNRS/UTC: study of a liver-on-a-chip model Read more
-
Expert Reviews: Basics of Microfluidics Why is a controlled shear-stress a key parameter of your microfluidic experiments? Read more
-
Microfluidic Application Notes Cancer Cell Analysis Made Easy with Aria: cell Capture and Labeling Read more
-
Microfluidic Application Notes Peristaltic Pump vs Pressure-Based Microfluidic Flow Control for Organ on Chip applications Read more
How important is the microlfluidic flow control in cell biology?
In drug discovery, it‘s important to control the flow rate of the sample used. As multiple formulations are tested, experimenters must be able to control flow rate while keeping the same level control of fluid handling at each stage of the experiment. DNA and RNA hybridization are often performed under a microscope. Manual injection over a microscope can be risky for the following reasons:
- A touch of pipette cone can misplace the dish and misrecord the position
- Samples can be flushed away during pipetting
- Liquid can be spilled over the microscope
Flow Controllers Available on the Market
Syringe Pumps
Multiple flow control technologies are available for sub-millimeter range fluid management. Syringe pumps are commonly used for fluid control. However, in microfluidics, particularly in microfluidics for cell biology, the use of syringe pumps is often problematic because the flow is not constant. This discontinuity is due to the mechanical system that creates an oscillating flow.
Manual Injection
Current methods for multiple fluid delivery, where microscopy techniques are simultaneously required and mostly made by manual pipetting action include , Immunolabeling, and DNA and RNA hybridization.. Manual injection can lead to uncontrolled and non-homogeneous fluid velocity, which can damage samples.
Pipette | Aria | |
---|---|---|
Type of injections | Abrupt injections (up to 1mL in few seconds) Disparate injections Turbulent flow | Smooth & controled injections Identical injections Laminar flow |
Geometry at injecion tip | Conic shape: Important shear strain Unhomogeneous fluid velocity | Straight shape: No modification at the injection tip |
Fluigent Pressure-Based Flow Control
As the demand for microfluidic pumps with higher flow stability, fast response time, versatility, and automation capabilities has increased, pressure controllers have become the device of choice for many users.
The working principle of such pumps is to pressurize the sample reservoirs to control the pressure drop between the inlet and the outlet of the microfluidic system. The responsiveness of the generated flow rate depends on the responsiveness of the pressure pump.
To overcome these issues, Fluigent’s Aria automates multiple fluid deliveries. The sample is preserved as the flow rate is controlled. Reproducibility increases as inter and intra operator variability are eliminated.

A new level of technology
Microscopy and cell biology
Flow cells or microfluidic chips combined with a fluid perfusion system and microscopy are compatible with a variety of applications, including DNA and RNA hybridization, drug combination and long-term perfusion, and immunostaining.
Cell culture and Organ-on-a-chip
This area is an ideal microenvironment to study molecular and cellular-scale activities that underlie human organ function as well as identify new therapeutic targets in vitro.
Digital PCR
Microfluidic dPCR offers a new level of insight compared to quantitative PCR (qPCR). Droplet-based microfluidics is an excellent solution for partitioning a sample.
Want to learn more about the capabilities of microfluidics in life science? See Fluigent’s CEO France Hamber discuss microfluidic disruptive discoveries
Research applications
Microfluidics in biology and medicine
Microfluidics has emerged as a transformative technology, revolutionizing various areas of research, diagnostics, and therapeutics. By enabling precise manipulation and control of small volumes of fluids at the microscale level, microfluidic devices, also known as lab-on-a-chip, have opened up new possibilities in the study of cells, diagnostics, DNA sequencing, and drug discovery. In biology, microfluidics allows researchers to analyze and manipulate individual cells, paving the way for advancements in cell biology and single-cell genomics. In medicine, microfluidic platforms offer portable, rapid, and cost-effective point-of-care diagnostics, bringing healthcare to resource-limited settings, e.g. by using organ-on-chip platforms.
As an example, microfluidics in life science has accelerated RNA sequencing technologies, enabling high-throughput sequencing at reduced costs. In the application note linked below, Fluigent presents the Drop-Seq method, a high-throughput method that enables sequencing of the mRNA from a large number of cells. The Drop-Seq method pairs barcoded beads and cells in droplets, capturing cell-specific RNA on beads. Tagged cDNA is generated, amplified, sequenced, and bioinformatically analyzed. Barcode sequences identify cells, and transcript sequences are mapped to a reference genome, forming cell-specific gene-expression profiles.
Microfluidic tools for cell biological research
Cellular biology plays a crucial role in the field of medical science and drives innovation. A comprehensive understanding of how cells react during infections and pathological conditions is instrumental in the discovery of novel disease treatments. Essential to the analysis and visualization of cellular behavior are microscopy and imaging technologies. In the realm of cell biology, the integration of precise fluid flow control within microfluidic systems has revolutionized the study of cells by providing an automated platform that mimics their natural environment.
Microfluidics facilitates the delivery of fluids at controlled flow rates, minimizing errors. It finds applications in diverse areas such as RNA and DNA hybridization, enabling real-time imaging of gene expression in living cells. Microfluidics also contributes to drug combination therapies, long-term perfusion studies, and improved immunostaining protocols. By replacing traditional methods, microfluidics in life science offers several advantages including enhanced control, sensitivity, throughput, cost-effectiveness, and reduced material consumption. Its potential impact extends to cancer diagnosis, enhancing our understanding of cancer biology, and driving advancements in medical research.
Advantages of pressure-based flow controllers for life science experiments
Pressure-based flow controllers offer several advantages over peristaltic pumps and syringe pumps in microfluidics for life science applications. Firstly, it provides precise and accurate control of flow rates, allowing for better reproducibility and control of experimental conditions. Secondly, the pressure-based system is less prone to pulsations and variations in flow, resulting in more stable and consistent flow profiles. Additionally, using pressure-based controllers in life sciences allows researchers to work with much smaller volumes, which is useful when the samples to be studied are expensive or rare.
Finally, using pumps like the Flow EZ allows for use of various accessories such as reservoir mixers or block heaters, which can reproduce the physiological conditions of cells, for example, and keep the sample homogeneous, which is much more complex, if not impossible, with other types of pumps.
Organ-on-chip studies for life science
Organs-on-chips (OoC) are microdevices that mimic organ functions. They use microfluidics and 3D culture to replicate human physiology. OoC models show that dynamic culture conditions affect system maturation. They aim to recreate tissue barriers, parenchymal tissues, and inter-organ interactions. An OoC system includes a microfluidic chip with cell culture chambers, fluid channels, and optional components like membranes or gels. Biosensors and bio-actuators may be added. This technology is very useful for microfluidics in life science applications, as it offers more realistic lab modeling of organs and tissues. To that end, Fluigent has created Omi, a versatile and automated platform for organ-on-chip studies.
Omi allows for long-term cell culture with controlled shear stress conditions through continuous flow. It offers customizable and automated protocols for various functions, such as perfusion, recirculation, sampling and injection. This platform caters to the requirements of both novice cell culture researchers and experienced organ-on-chip researchers, addressing their needs for automation and reproducibility.
Microfluidic in Life Science Case Study
Hans-Knöll-Institut, New Antibiotics, Cultivation in Droplets
This project focuses on how Fluigent’s customers use microfluidics to achieve outstanding results in their technology experiments.
Our speakers are Prof. Dr. Miriam Agler-Rosenbaum (Head of Bio Pilot Plant Department), Dr. Sundar Hengoju, Dr. Dede Man from the Bio Pilot Plant Department of the Leibniz Institut for Natural Products Research and Infection Biology (Hans Knöll Institute).
- How are they trying to find new antibiotics?
- Why is this important for infection biology?
- How do they research natural products?
- What are these products exactly?
- How does microfluidics allow them to cultivate microbes in droplets?
- How does the technology increase their efficiency millions of times over?
- In which cases are pressure pumps better than syringe pumps?
- How can microfluidic droplets be stabilized?
Watch this episode to find out – and note that this is just one story told. There are many possible applications for microfluidics.
Related products
Research field
Fluid Degassing Device for Microfluidic System
Microfluidic Fluid Degassing Device
See the offerMicrofluidic Injection Valve
L-SWITCH™ 6-port/2-position
See the offerAutomated Perfusion System for Spatial Omics
Aria
See the offerHigh Throughput Cell Perfusion Pack
High Throughput Cell Perfusion Pack
See the offerOrgan on Chip Perfusion Pack
Perfect organ-on-chip cell perfusion set
See the offerMicrofluidic flow controller
Flow EZ™
See the offerMicrofluidic Recirculation Valve
L-SWITCH™ 6-port/2-position
See the offerBidirectional Microfluidic Flow Sensor
FLOW UNIT | FLOW UNIT +
See the offer
Industrial field
Related Expertises
Looking for another market?
From the life sciences to the food industry, many applications require the use of fluids driven at flow rates from nanoliters to milliliters per minute. At such low flows, the success of these applications strongly depends on the level of control and automation of the fluidic operations.
These applications require flow control systems that are adapted for ensuring their success.
Microfluidic chip definition
Microfluidic chips, often referred to as lab-on-a-chip devices, are miniature platforms that manipulate and analyze small volumes of fluids. These chips, witch feature molded or patterned micro-channels, integrate various functions, such as mixing, pumping, and sensing, onto a compact substrate, enabling precise control over minute amounts of liquids.
Inlet and outlet ports connect this network to the external environment. Liquids or gases can be injected, managed, and removed from the microfluidic chip through passive or active methods, wich may involve pressure/flow controllers, syringe pumps, or peristaltic pumps. The microscale fluidic chip’s channels may have varying inner diameters, typically ranging from 5 to 500 µm, but today’s fabrication techniques enable structures with sub-micrometer precision.
The channel network must be specifically designed for the desired application and analysis (cell culture, organ-on-a-chip, DNA analysis, lab-on-a-chip, microfluidic droplets, etc.).
A Brief History of Microlfuidic Chips
The roots of microfluidics trace back to the mid-20th century. However, it was in the late 20th and early 21st centuries that the field truly blossomed.
Miniaturization techniques have been continuously shaping the microelectronic’s technology and its ability to produce devices for a broad range of applications. Downscaling the dimensions of transistors has been pursued in the industry to fulfill the growing demand for smaller, faster and more energy-efficient systems1. In the late 1960s, a new field emerged known as microelectromechanical systems (MEMS).
This field laid the foundations for the miniaturization of mechanical systems, with the development of micromachining technology based on silicon semiconductor technology. It was during this era that engineers began realizing the capabilities of silicon chips in processing elements such as chemicals, motion, and light.
1950s-1970s: Early Developments
Pioneering work by scientists like Norbert Elmqvist and Andreas Manz laid the groundwork for microfluidic concepts.
1980s-1990s: Emergence of Lab-on-a-Chip
The term “lab-on-a-chip” gained prominence as researchers explored ways to miniaturize and integrate laboratory processes.
2000s-Present: Rapid Advancements
Microfluidic chips found applications in various fields, including biology, chemistry, and medicine, driving a surge in research and development.

Key Milestones:
First Lab-on-Chip (1979):
In 1979, the first glimpse of the future emerged as Andreas Manz pioneered the concept of a lab-on-a-chip, laying the foundation for a revolutionary era in microfluidics.
Polymerase Chain Reaction (PCR) on a Chip (1998):
The demonstration of PCR on a microfluidic chip by the Quake group showcased the potential for DNA amplification in a miniaturized format.
Organ-on-a-Chip (2010s):
Advancements in mimicking physiological conditions on microfluidic platforms led to the development of “organ-on-a-chip” devices, revolutionizing drug testing and disease modeling.
Point-of-Care Diagnostics (2010s):
Microfluidic chips played a pivotal role in the development of portable, rapid diagnostic devices, transforming healthcare by enabling on-site testing.
Drop-Sequencing protocol developed by Macosko et al. (2015)
Drop-Seq marked a significant milestone as it introduced a high-throughput method for single-cell RNA sequencing, propelling advancements in understanding cellular diversity and gene expression.
Material and production methods
Explore the world of microfluidic chip fabrication and production methods. These chips, crucial in lab-on-a-chip technology, are crafted from materials like silicon, glass, or polymers such as PDMS (Polydimethylsiloxane). The production methods vary, tailored to the chosen material.

The evolution of microfluidics traces back to the late 20th century with the development of inkjet printer heads. This breakthrough showcased the generation of micron-sized droplets using piezoelectric or thermal effects.
In 1990, Manz et al. introduced the concept of miniaturized total chemical analysis systems (μTAS)2, aiming to integrate diverse laboratory processes into a compact chip-sized platform.
This revolutionary idea sought to simplify and enhance complex chemical analyses by minimizing the size and complexity of traditional laboratory setups.
Subsequently, companies emerged, utilizing these systems for life science applications. The adoption of rapid prototyping and polymer replication, particularly PDMS, as an alternative to silicon processing, accelerated academic research. This era ushered in new terminologies such as “microfluidics” and “lab-on-a-chip” (LOC), reshaping the landscape of scientific exploration.
Microfluidic Chip manufacturers

Beonchip S. L. was founded in 2016 at the University of Zaragoza by Ignacio Ochoa (specialist and PhD in biology), Luis Fernández (PhD in microtechnology) and Rosa Monge (PhD in mechanical Engineering).
Therefore, Beonchip have multidisciplinarity in its roots, and their team is proof of that. The collaboration of engineers and biologists has been key to design the most user friendly and accessible organ on chip devices that are true to the physiological environment of the body.

FlowJEM technology was developed for research and development projects by microfluidic researchers and engineers like you.
Microfluidic devices fabricated by FlowJEM have a broad range of applications, including but not limited to chemistry, materials science and technology, nanoscience, pharmaceutical science, biology, bioengineering and medicine.
FlowJEM’s goal is to meet the demands for high quality, fast turnaround time and low cost. Work with us to develop your ideas into prototypes or transition your prototypes to volume production.

Secoya Technologies develops innovative production technologies and equipment by a smart use of intensified operational units. It results in stable and reliable processes – at any scale – producing high quality (bio-)pharmaceutical products
Using cutting-edge technologies as sub-micrometric 3D printing and micro-electro-erosion, SECOYA has developed a unique device that is able to continuously produce micro-sized droplets at a very high frequency (kHz) and with a very narrow size distribution (high monodispersity). Its use for the encapsulation of active ingredients and multiple emulsions has been demonstrated.

microfluidic ChipShop offers a wide off-the-shelf selection of microscale fluidic chips from thermoplastic polymers and the complementary accessories. They furthermore support customized prototyping as well as volume production services – from one to millions of chips, from simple microfluidic devices to complex lab-on-a-chip-systems.


Bi/ond empowers biological innovation by engineering microchips which nourish, stimulate and monitor your cells. Bi/ond’s Organ-on-Chips are compatible with a wide variety of complex 3D tissues (organoids, patient-derived samples, cell monolayers) and they have been qualified in multiple applications such as Brain-on-Chip, Heart-on-Chip and Cancer-on-Chip. When you buy one of our OOC, you are not only purchasing a product, you are adding an engineer to your team. Bi/ond’ team will help and support you to set up your model with our extensive knowledge of microfabrication, simulations and biology.


Micronit is the leading innovator and global partner in design, development and manufacturing of customer specific lab-on-a- chip solutions for life science and health applications.
With over 20 years of experience, a highly qualified team, state-of-the-art technologies, and certified manufacturing facilities, we deliver innovative and competitive products to our customers for life science research towards personal health applications.

References
- Chiu, J. and Chie
- Temiz, Y., Lovchik, R. D., Kaigala, G. V. & Delamarche, E. Lab-on-a-chip devices: How to close and plug the lab? Microelectron. Eng. 132, 156–175 (2015).
- A. MANZ, N. G. and H. M. W. Miniaturized Total Chemical Analysis Systems: a Novel Concept for Chemical Sensing. Sensors and Actuators 17, 620–624 (1990).
Related Resources
- Expert Reviews: Basics of Microfluidics
Microfluidic Flow Control: Comparison between peristaltic, syringe and pressure pumps for microfluidic applications
Discover - Microfluidics White Papers
An exploration of Microfluidic technology and fluid handling
Discover - Expert Reviews: Basics of Microfluidics
Microfluidics overview: History and Definition
Discover - Expert Reviews: Basics of Microfluidics
Instrument Stability in Microfluidics
Discover - Expert Reviews: Basics of Microfluidics
How to choose a microfluidic chip
Discover - Expert Reviews: Basics of Microfluidics
Microfabrication of Microfluidic Chips: Materials and Methods
Discover - Expert Reviews: Basics of Microfluidics
Application of microfluidic chip technology
Discover - Expert Reviews: Basics of Microfluidics
The Raydrop | A new droplet generation device based on non-embedded co-flow-focusing
Discover - Microfluidic Application Notes
Automating Neuronal Cell Immunofluorescence in Microfluidic Chips
Discover
About The Keyser lab – University of Cambridge
The Keyser Lab is a group of researchers at the Cavendish Laboratory, University of Cambridge, UK. Since its founding in 1874, the Cavendish Laboratory has been at the forefront of discovery in physics, with a core focus on experimental physics supported by excellence in theory. The department promotes world-leading experimental and theoretical physics in all its diversity. Scientists from the Keyser Lab study the physics of ions, macromolecules and particles, with a particular focus on particles in confined geometries at the single molecule/particle level. To exert maximum control over all parameters for their experiments, they make use of several cutting-edge techniques such as DNA self-assembly (origami), optical trapping, electrophysiology, and microfluidics and nanofluidics.
The team includes researchers with expertise in physics, engineering, physical chemistry, biochemistry/biology, and micro- and nanofabrication.


What are Giant Unilamellar Vesicles (GUVs)?
Giant Unilamellar Vesicles (GUVs) are micron-sized compartments composed of lipid bilayers, serving as models for cell membranes or as encapsulating structures for biological materials within cell-like environments. These vesicles have dimensions ranging from 1 to 100 µm, mimicking the size of cells. Like natural cell membranes, GUVs are constructed from lipids, predominantly phospholipids and cholesterol. The amphiphilic properties of these lipids enable them to spontaneously arrange into spherical compartments when immersed in an aqueous solution.
They offer the advantages of having well-defined lipid compositions, being easy to image, and being controlled systems for studying transport processes. These characteristics open the door to a variety of applications in biology and biomedicine, especially membrane biophysics and synthetic biology.1,2

Working principle of GUV production

In 2016, the Dekker Laboratory from the Delft University of Technology developed a novel microfluidics-based method called Octanol-Assisted Liposome Assembly (OLA) to create uniform, cell-sized (5–20 mm) GUVs with high encapsulation efficiency. Using Fluigent’s pressure-driven MFCS-EZ controller with the Oxygen software tool, an inner aqueous phase (IA) and an outer lipid-carrying 1-octanol phase (LO) were combined, resulting in double-emulsion droplets via hydrodynamic flow focusing. These droplets developed a side-connected 1-octanol pocket, which, due to interfacial energy minimization, separated to rapidly form fully assembled solvent-free liposomes. Microfluidic GUV production addresses the persistent issue of residual oil in vesicle bilayers.
This method allows researchers to generate GUVs with higher monodispersity and greater size control compared to traditional methods, and with a faster process than alternative microfluidic methods.3
Keyser Lab: Microfluidics for GUV generation for antimicrobial efficacy and biomimetic vesicle membrane testing
Scientists from the University of Cambridge integrated octanol-assisted liposome assembly into their microfluidic platforms (“lab on a chip” devices) for quantifying drug permeation and antimicrobial efficacy on biomimetic vesicle membranes.
In a first paper published in Lab on a Chip (2019), they reported on a microfluidic platform for testing antimicrobial peptides on artificial vesicle membranes. This platform produced vesicles with an encapsulated dye to assess the efficacy of antimicrobial peptides by measuring the time it takes for vesicles to lyse.4
This Giant Unilamellar Vesicle production technique also utilized Fluigent‘s MFCS-EZ and its accompanying software (Oxygen) for fluid control. Vesicle formation and perfusion inlets were connected, and the microfluidic chip was loaded with an inner aqueous phase base stock. The outlet was connected to Fluigent’s 2-Switch, which can switch between open or closed configurations for waste removal. Vesicles flowed through a channel to the connector chip, and 1-octanol pockets pinched off to form droplets. Density-based separation removed vesicle production waste, and the vesicles were distributed to trapping chambers. Peptide doses were controlled, replacing the inner aqueous phase buffer, while maintaining a constant input pressure. The entire process was monitored under an inverted microscope.
Validated with cecropin B on bacterial-mimicking membranes, the platform enabled the researchers to study over 1000 vesicles simultaneously. The results showed dose-dependent disruption of vesicle membranes, demonstrating the platform’s potential for controlled, quantitative assessments of the efficacy and selectivity of antimicrobial peptides. This microfluidic approach to GUV production is suggested as a new standard for pre-clinical development of membrane-active antimicrobials, offering advantages in cost efficiency and parallelization.


In another paper published in Biomembranes (2020), scientists from the University of Cambridge and the University of Exeter produced GUVs with tunable binary lipid mixtures to determine lipid diffusion in OLA vesicles.5
The focus was on expanding the capabilities of this microfluidic approach to form GUVs with tunable binary lipid mixtures. An MFCS-EZ equipped with a Fluiwell-4C reservoir kit with OLA solutions was connected to the microfluidic chip. The microfluidic GUV production method allowed for a high degree of control over vesicle sizes by adjusting pressures in different channels. This was possible due to the high responsiveness, stability and repeatability of the pressure generated by the MFCS-EZ. In addition, flow speed was successfully matched to the outlet channel length to prevent residual octanol attachment to vesicles.
This study employed fluorescence recovery after photobleaching to investigate lipid lateral diffusion coefficients in GUVs produced by the microfluidic approach, finding values within the expected range. Comparisons with electroformed vesicles indicated quantitative similarity in lipid diffusion coefficients. The results served as a quantitative biophysical validation of OLA-derived GUVs, enhancing the potential application of this versatile platform in drug discovery, artificial cell production, and lipid membrane studies.



Conclusion
To produce Giant Unilamellar Vesicles, fluids were controlled using Fluigent pressure-based flow controllers. Researchers from the Keyser Lab (University of Cambridge) typically operated the chip with input pressures of 40 mbar for the inner aqueous phase and dissolved-lipid phases and 100 mbar for the outer aqueous phase. For precise flow measurements, Fluigent Flow Units can be added on the fluidic path. Microfluidic GUV production also allowed researchers to adjust the sizes of the generated vesicles by adjusting the microfluidic pressures of the phases. This degree of control is difficult to achieve using standard methods such as electroformation or traditional syringe pumps.

Testimonials

“Microfluidics presents various advantages to researchers who need small volumes and high throughput in answering their scientific questions. In our lab, we use microfluidic devices for standardization and control of experimental parameters like concentration and timing. In the complex (biological) systems we are working on, the mentioned characteristics are fundamental in collecting reliable meaningful statistics, and microfluidics in combination with light microscopy offers just that. We also heavily rely on the ability to rapidly prototype devices, as we can design bespoke solutions at minimal production cost and time.”
“We use the pressure-based pumps from Fluigent for experiments that require swift responsiveness when manipulating fluids, and fine tuning at low flow rates. We use the Fluigent systems during fabrication and running of the microfluidic chips. The ability to pump in air at high precision makes the Fluigent pressure-based systems ideally suited to selectively coat and functionalize micro-channels within a microfluidic network. After coating we then fill the devices with the experimental solutions and use the pressure controls to move fluids around, open and close valves and carefully time the introduction of small molecules in the experiments.“
Kareem Al Nahas, University of Cambridge
Expertises & Resources
-
Expert Reviews: Basics of Microfluidics Giant Unilamellar Vesicles (GUVs) Production using Microfluidics Read more
-
Microfluidics Article Reviews A mRNA encapsulation platform integrating Fluigent’s FlowEZ Read more
-
Expert Reviews: Basics of Microfluidics Microfluidics for vaccine development Read more
-
Microfluidic Application Notes Liposome Nanoparticle Synthesis Read more
-
Expert Reviews: Basics of Microfluidics Flow control for droplet generation using syringe pumps and pressure-based flow controllers Read more
References
- Naziris, N., Demetzos, C. (2021). Liposomes: Production Methods and Application in Alzheimer’s Disease. In: Vlamos, P. (eds) GeNeDis 2020. Advances in Experimental Medicine and Biology, vol 1339. Springer, Cham.
- Pereira, David & Valentão, Patrícia & Andrade, Paula. (2014). Nano- and Microdelivery Systems for Marine Bioactive Lipids. Marine Drugs. 12. 6014. 10.3390/md12126014.
- Deshpande, S.; Caspi, Y.; Meijering, A. E. C.; Dekker, C. Octanol-Assisted Liposome Assembly on Chip. Nat Commun 2016, 7 (1), 10447.
- Al Nahas, K.; Cama, J.; Schaich, M.; Hammond, K.; Deshpande, S.; Dekker, C.; Ryadnov, M. G.; Keyser, U. F. A Microfluidic Platform for the Characterisation of Membrane Active Antimicrobials. Lab Chip 2019, 19 (5), 837–844.
- Schaich, M.; Sobota, D.; Sleath, H.; Cama, J.; Keyser, U. F. Characterization of Lipid Composition and Diffusivity in OLA Generated Vesicles. Biochimica et Biophysica Acta (BBA) – Biomembranes 2020, 1862 (9), 183359.
Fluigent microfluidic research equipment presents OxyGEN
Interact with your instruments through an all-in-one screen to control and monitor pressures, flow rates, valve positions and more in real time. Other capabilities include the ability to build time-based protocols and automate any experiment.
Which instruments and packages to choose to replace old setups ?
The wide variety of solutions offered by Fluigent for use in microfluidic and nanofluidic applications provide more control, automation, precision, and usability. If you’re looking to replace high-precision syringe pumps or other conventional devices, we provide cutting-edge microfluidic systems and components that increase productivity.
Our innovative pressure-based microfluidic controllers are compatible with lab on a chip device and a wide variety of microfluidic technologies that will allow users to focus on the science, not on the setup.
Our microfluidic research equipment has been tested in a large number of applications in various industries (life science, water management, cosmetics , food, etc.). We offer flow and pressure controllers that ensure results with high precision and reproducibility due to their pulseless flow, sensors that control and monitor flow rate directly, microfluidic valves, vacuum and pressure sources, microfluidic chips for droplet generation and for organ-on-a-chip studies, and various accessories perfect for your set up.
What are the research applications possible?
Fluigent was the first company to introduce pressure-driven flow control to the microfluidic research market as opposed to conventional syringe and peristaltic pumps.
As a pioneer in microfluidics, we set the standard for microfluidic control and strive to stay on the cutting edge of science. We created content on microfluidics, microfluidic devices, comparison, and much more to share with the scientific community.
Our microfluidic research equipment allows us to obtain optimal and promising results in all fields of research. In cellular analysis, flow control is a very important parameter, allowing non-invasive studies at the single-cell level and improving precision.
In organ-on-a-chip & cell culture studies, microfluidics enables one the unique ability to control a cellular microenvironment with high spatiotemporal precision and to present cells with mechanical and biochemical signals in a more physiologically relevant context.
In cell biology, precise flow control, combined with microscopy tools and cell biology experiments, allows for the creation of an automated environment where the cell can grow in the relevant physiological environment.
In droplet & particle generation, our microfluidic equipment for research application allows users to carry out experiments where high monodispersity and reproducibility are required (digital PCR, single-cell encapsulation in droplets etc.), as well as in cases where an expensive API is used, as it greatly reduces waste.
Abstract
In this Application Note, we introduce a novel Automated Immunofluorescence (IF) protocol that integrates the advanced automated sequential injection system (ARIA) and Bioptechs’ FCS2 imaging chamber. This combination offers a breakthrough solution for researchers to achieve highly accurate and reproducible imaging results in cell and molecular biology experiments, providing a deeper insight into the intricate cellular and molecular interactions within the sample.
With this Automated IF protocol, the tedious and error-prone manual handling associated with traditional multi-step IF procedures is completely eliminated, resulting in a faster and more reliable process.
The application note was prepared in collaboration with Samy GOBAA (Director of the Biomaterials and Microfluidics Unit at the Pasteur Institute) and Heloïse Mary (Research Engineer at BMcf).
Introduction to Automated Immunofluorescence
Immunofluorescence (IF) is a widely utilized analytical technique in the field of cell and molecular biology, aimed at providing insights into the localization and distribution of specific proteins within cells, tissues, and organisms. The technique employs the use of antibodies, which can be conjugated with fluorescent markers or revealed through the use of secondary fluorescent antibodies, to target the specific proteins and enable visualization through the use of fluorescent microscopy. (1)
Automated immunofluorescence streamlines the multistep process of IF, which comprises several crucial steps, such as cell fixation, cell permeabilization, blocking of nonspecific binding sites, and direct or indirect staining, followed by several washing steps. The traditional approach to performing these steps has been through manual pipetting, however, this method is time-consuming and prone to inaccuracies due to human error in terms of solution volume and flow rate (2).
In recent times, there has been a growing emphasis on automating laboratory protocols to enhance the efficiency, accuracy, and reproducibility of results. Microfluidics has played a significant role in this advancement, by offering precise control of fluid flow and volume in complex analytical procedures such as IF.
In this application note, we present an Automated Immunofluorescence Protocol that leverages the capabilities of the automated sequential injection system, ARIA, in combination with the imaging chamber FCS2 from Bioptechs. This protocol offers a marked improvement in terms of accuracy and reproducibility, compared to the traditional manual pipetting method, while also increasing the overall efficiency of the process.
The fluid delivery procedure is coupled with the Zeiss Axio Observer for imaging purposes, although the protocol can be adapted to other imaging systems.
We are grateful to Samy GOBAA (Head of the Biomaterials and Microfluidics core facility at Institut Pasteur) and Heloïse Mary (Research Engineer at BMcf) for their contributions to this application note, including the provision of essential lab equipment and invaluable advice.
Materials & Methods: Immunofluorescence protocol
Materials:
- ARIA single output
- Bioptechs Live Cell Imaging Chamber (FCS2)
- Widefield Microscope (in this app note we used a Zeiss Axio Observer)

Methods :
To perform the automated immunofluorescence protocol, preliminary steps of cell preparation and FCS2 chamber preparation are necessary.
- Cell and coverslip preparation: Clean and coat round coverslips (40mm) with EtOH 70%, plasma, and collagen at 50µg/ml. Incubate for 1h @ 37°C. Seed HUVECs onto coverslips in EGM-2 medium for 1-2h to adhere.
- Fixation (manual or automated): Wash cells with PBS 1X, then fix with 4% PFA in PBS 1X for 20min. Rinse with PBS 1X to remove PFA.
- FCS2 chamber assembly: Mount coverslip on white part of chamber, hydrate with PBS 1X, close chamber, and place on microscope stage.
- Automated Immunofluorescence: Permeabilize with 0.1% Triton 100X in PBS 1X for 15min, wash with PBS, block with PBS 1X + 2% BSA for 20min, wash with PBS, and stain with a cocktail of fluorescent antibodies (DAPI, Phalloidin-AF488, UEA-1-lectin DyLight 647).
ARIA unit preparation:
To create a custom automated immunofluorescence program, ARIA needs to be prepared.
- Connect ARIA to pressure source (either a FLPG unit or directly on the wall pressure source), min. 2.2 bar and computer using USB cable.
- Open ARIA software and calibrate the unit.
- Create custom IF program:
- Add steps by clicking “plus” button.
- For solution injection, choose “Volume Injection” and select reservoir.
- Set fluid delivery parameters (flow rate and volume).
- For incubation, add “Wait” step after injection and set timing.
- Repeat steps for entire IF protocol.


Results: Image acquisition

To acquire our images, we here used a Zeiss Axio Observer (inverted widefield microscope).
Please note that any microscope can be used to acquire your images as for any IF experiment.
Figure 3. Primary human endothelial cells (HUVECs) stained with Phalloidin-AF488 for F-actin visualization, UEA1-lectin-DyLight as a membrane marker of endothelial cells and DAPI for nuclei staining. Images were acquired on a Zeiss widefield microscopy at 40X magnification.
Conclusion
This Application Note highlights the benefits of using the ARIA system and the FCS2 imaging chamber for automated immunofluorescence procedures. Our findings demonstrate that this method results in a faster and more efficient process, with a total time of 4 hours and 30 minutes. This is a significant time saving compared to traditional manual pipetting, which can take up to 1 hour and 30 minutes longer.
The automation of this process allows researchers to perform other tasks simultaneously, freeing up valuable time and resources. Furthermore, this protocol is versatile and can be applied to cells on coverslips and cells or tissues in microfluidic chips, making it a useful tool for cell and molecular biology research.
References:
- Im K, Mareninov S, Diaz MFP, Yong WH. An Introduction to Performing Immunofluorescence Staining. Methods Mol Biol. 2019;1897:299-311. doi: 10.1007/978-1-4939-8935-5_26. PMID: 30539454; PMCID: PMC6918834.
- Lim, Jeffrey Chun Tatt & Yeong, Joe & Lim, Chun Jye & Ong, Clara & Wong, Siew-Cheng & Chew, Valerie & Ahmed, Syed & Tan, Puay & Iqbal, Jabed. (2018). An automated staining protocol for 7-colour immunofluorescence of human tissue sections for diagnostic and prognostic use. Pathology. 50. 10.1016/j.pathol.2017.11.087.
Related content
A Université Paris-Saclay, CEA, CNRS Paper
Paper: Sipos, E. H.; Léty-Stefanska, A.; Denby Wilkes, C.; Soutourina, J.; Malloggi, F. Microfluidic Platform for Monitoring Saccharomyces Cerevisiae Mutation Accumulation. Lab Chip 2021, 21 (12), 2407–2416. https://doi.org/10.1039/D1LC00086A.
This paper, published in Lab-on-Chip (2021), is a joint research work between the Interdisciplinary Laboratory on Nanoscale and Supramolecular Organization (LIONS) and the Institute for Integrative Biology of the Cell (I2BC) from the CEA/CNRS/Université Paris-Saclay.

The LIONS investigates nanostructured materials for practical applications in energy, environment, and health. They focus on safe and eco-friendly synthesis methods using statistical physics and advanced instrumentation, generating new knowledge and fostering commercialization through patents, licenses, and start-ups. Through a microfluidic team led by Dr. Florent Malloggi, their research work in microfluidics addresses a variety of challenges in fundamental chemistry, interface physics, and designing microfluidic chips for medical diagnostics and biotechnology.
The I2BC carries out research in the integrative biology of the cell around four thematic axes (expression and evolution of genomes, cell compartment and transport, stress and adaptation, and metabolism and bioenergy). Led by Dr. Julie Soutourina, the Genome Transcriptional Regulation (GTR) team from I2BC studies how genes are regulated at a genomic level, with a focus on the Mediator complex’s role in RNA polymerase II regulation. They use yeast and human cells to understand how transcription and other nuclear processes like DNA repair are coordinated.
The LIONS and I2BC teams combined their expertise in microfluidics and genome understanding to develop an automated microfluidic platform, including Fluigent’s Flow EZ, for investigating mutation accumulation (MA). This approach highly reduced the experiment time and human intervention compared to traditional techniques.
Why is studying DNA mutations fundamental for advancing our understanding of genetics and human health?
Mutations serve as the driving force behind genetic diversity. They are necessary for evolutionary processes and also linked to diseases, notably cancer. In fact, mutations can arise naturally as cells divide throughout a person’s life. It is believed that a few dozen mutations occur during each cell division when DNA replicates.
On the other hand, DNA can undergo changes due to environmental factors, such as exposure to UV radiation, smoking, asbestos, or specific viruses. Therefore, it is vital to understand how mutations occur on a genomic scale.1,2 Nonetheless, studying concealed mutation events and their outcomes presents a challenge, as natural selection often obscures them from a biologists’ view.
How can we study hidden mutations and their effects without the impact of natural selection?
One of the main experiments used to study these mutation rates is mutation accumulation. It involves the expansion of a cell population from a single common ancestor under controlled conditions (such as in the presence of a molecule or when the ancestor’s genome contains a mutation of interest).
After several generations, a single daughter cell is unbiasedly isolated (creating a bottleneck population, thus minimizing natural selection), which then becomes the exclusive ancestor of a cell population that multiplies over numerous generations, continuing the cycle.
When complemented with high-throughput genome sequencing, this approach enables the precise mapping of spontaneous mutations, and the quantification of their occurrence rate, while also characterizing their effects on the phenotype.3,4

How are mutation accumulation experiments traditionally done?

As the mutation rates are typically very low, classical mutation accumulation experiments are labor-intensive and time-consuming. They involve growing cells through a significant number of repeated plating on agar plates and introducing bottlenecks by randomly selecting a single colony at each step, a process that takes, for instance, two days for budding yeast at 30 °C.
This means that more than six months (and 800 Petri dishes) is required to achieve 100 single-cell bottlenecks in yeast mutation accumulation.
Additionally, the human intervention every 48 hours (the time it takes for individual yeast colonies to form) introduces bias, as the choice of a colony may not be entirely random and could be a non-random choice of mutants with higher fitness.
Also, human intervention can alter the cell growth environment by introducing bacterial or fungal contamination.
How can microfluidics automate mutation accumulation experiments?
Since its emergence in the early 1990s, microfluidics has automated laboratory experiments, offering advantages like high throughput, minimal material consumption, reduced cross-contamination, and small sample requirements.6
With this perspective, the researchers from LIONS and I2BC developed an automated microfluidic-based platform for mutation accumulation experiments based on budding yeast over many generations inside a specific microfluidic device.
Coupled with high-throughput sequencing, this approach simplifies and accelerates the process of measuring mutational profiles at the genome level with minimal human intervention.

How to set up a microfluidic platform for mutation accumulation
First, the cells chosen for the study were yeast Saccharomyces cerevisiae as they are an excellent unicellular eukaryotic model. In addition, they possess a compact genome and a short generation time compared to human cells.
The strategy behind the microfluidic device is based on linear arrays of culture chambers where yeast populations grow for many generations. A narrow channel acts as a bottleneck, allowing only one cell to pass to a neighboring chamber. This single daughter cell then replicates until it occupies the entirety of the second chamber.
Afterward, another single daughter cell proceeds to the following chamber, and this cycle continues. This setup mimics the single colony-forming units in manual experiments. In one microfluidic device, 8 parallel channels enable 8 MA lines simultaneously.
To maintain growth for extended periods, nutrient channels connected by small diffusion channels are incorporated into the design, with Fluigent’s pressure-driven controller FlowEZ and FlowUnit regulating nutrient flow (8 µL/min) into the device.
Yeast growth was monitored using light microscopy, and after growth, yeast cells were collected for genome sequencing. To validate this microfluidic approach, the accumulation of mutations was done on two different genetic backgrounds, a wild-type strain and a base-excision DNA repair mutant characterized by a well-defined mutational profile.

Proof of concept: Enhancing mutation accumulation experiments with minimal human intervention and time.
Through time-lapse imaging, it is possible to precisly follow the cell divisions and growth of yeast within the microfluidic device and their random movement into the following chambers. When a yeast cell reached a new chamber, it endured division and took over the chamber as demonstrated in the video, thus confirming the efficiency of the chip design.
The stable and precise nutrient flow, set up through the Flow EZ and Flow Unit, ensured long-term cell culturing.

The high-throughput genome sequencing results also confirmed that the microfluidic device successfully detected the specific mutational signature and enabled accumulation of mutation in a way comparable to the classical method (figure 6).

This approach presents several advantages compared to the classical mutation accumulation method:
- Reducing time and number of steps, which traditionnaly involves 800 Petri dishes and frequent human intervention over a period of more than 6 months. A single microfluidic chip with up to 8 mutation accumulation lines running in parallel required 3 months and minimal intervention, typically once every two weeks, to ensure the device’s proper functioning.
- Automating the hand-picking step of a single colony, thus eliminating the bias associated with human intervention and consequent contaminations.
- Providing a controlled growth environment in terms of temperature, and flow of nutrients.
Conclusion
In this paper highlight, E.Sipos et al., from the LIONS and I2BC research groups (CEA-CNRS-Université Paris-Saclay), developed a microfluidic device that streamlined mutation accumulation experiments, reducing the time required from over 6 months to 1-4.5 months. It allows parallel analysis of multiple yeast strains, facilitating unbiased genome-wide mutational process comparisons.
The device holds promise for identifying mutagenic compounds and discovering new therapeutic targets. It may also help in developing human cell culture systems to replicate mutation accumulation in diseases like cancer.
Related products
Related Resources
- Expert Reviews: Basics of Microfluidics
Flow control for droplet generation using syringe pumps and pressure-based flow controllers
Read more - Expert Reviews: Basics of Microfluidics
Micropipette aspiration of cells and tissues
Read more - Expert Reviews: Basics of Microfluidics
Prostate Organoid Culture in Microbeads
Read more
References
- (1) P. L. Foster, in Methods in Enzymology: DNA Repair, Part B, 2006, vol. 409, pp. 195–213.
- (2) A. Frenoy and S. Bonhoeffer, PLoS Biol., 2018, 16, e2005056.
- (3) J. E. Barrick and R. E. Lenski, Nat. Rev. Genet., 2013, 14,827–839.
- (4) V. Katju and U. Bergthorsson, Genome Biol. Evol., 2019, 11,136–165
- (5) D.L. Halligan andP.D. Keightley, Annu. Rev. Ecol. Evol. Syst. 2009, 40 (1), 151–172.
- (6) L. Y. Yeo, H. C. Chang, P. P. Y. Chan and J. R. Friend, Small,2011, 7, 12–48.
Features of our compact flow controller
Expand as needed
Combine up to 8 modules as your work flow grows. Each microfluidic flow regulator is a separate and independant pressure channel.
Pressure and vacuum control
The Flow EZ™ range of modules allow for regulation of pressure / vacuum down to -800 mbar and up to 7 bar.
Local control
Control without a PC using the Flow EZ™ hardware interface with one hand. Focus on the experiment instead of looking at the PC.
Precise volume delivery
When combined with a FLOW UNIT, one can control flow rate directly or deliver dispensed volumes as needed.
Various reservoir sizes
Support reservoir sizes from 2 mL to one liter laboratory bottles. The Flow EZ™ can maintain continuous, pulseless flow for days without refilling.
Highlights
The Flow EZTM, a state-of-the-art microfluidic flow controller
Based on our industry leading experience, Fluigent has developed the patented pneumatic system: the most advanced microfluidic pumping technology available. It is at the heart of the Fluigent’s next generation performance providing the fastest, most stable, and compact microfluidic system In the base configuration, the system controls the pressure or vacuum, and the liquid flow is a function of system resistance, fluid viscosity, etc. The addition of a FLOW UNIT enables one to control or monitor flow rate as well as measure a dispensed volume. The pressure automatically adjusts in the background to maintain the set flow rate.
When combined with the LINK module, the Flow EZ™ flow controller’s capabilities are extended by using Fluigent software to control the system or to generate time based protocols and record data (OxyGEN software).
The Flow EZ™ microfluidic flow controller modules are available in different pressure and vacuum ranges to provide the optimum level of pressure control and resolution. These can easily be combined to match all application requirements or reconfigure the system for a new experimental design.


“We are really happy with Flugent microfluidics control systems: they are very EZ to use; they are also robust and reliable. We want to highlight in particular the user-friendliness of the software (OxyGEN), and the ease with which one can implement their own third-party programs to embed Fluigent controllers to a bigger setup comprising multiple units from different manufacturers.”
Prof. Artem Mishchenko – Université de Manchester
Discover the most advanced microfluidic flow regulator
With a compact and modular design, this microfluidic flow controller allows you to set and benefit quickly from the pressure-based flow control advantages for your experiments.
A response time ten times faster compared to syringe pumps.
With the use of pressure instead of mechanical action, the Flow EZTM microfluidic flow controller gets a responsiveness ten times faster than syringe pumps. A low response time allows users to quickly execute operations such as stop flow and pressure/flow rate steps.
Control flow rate with the benefits of responsive, pulse-free flow
Pulse-free flow is critical for generating high quality and repeatable results. The Microfluidic flow controller integrates the all-new DFC (Direct Flow Control) algorithm. This allows users to set a flow rate directly on the instrument display. The applied pressure will automatically adjust to maintain the flow rate.

“We came to Fluigent when we were building an automated microfluidic platform for screening chemical reactions. Fluigent products are powerful in precise control of the flow conditions and can guarantee the performance of our platform. The pump system is user-friendly and can be extended to complex experimental systems where multiple pumps are needed. The above merits have made our experimental design process smooth and easy.”
Dr. Huizhi Wang- Imperial College London
Part of our LineUp Series
Pressure and vacuum control, flow rate control, microfluidic valve automation, and software control. Select and combine the modules you need from our range of LineUp™ products. Our devices have become the gold standard for microfluidic flow control over the years.
Webinar- Flow Control in Microfluidics
Discover the performance, advantages of limitations of common flow controllers, including pressure pumps.
In this session, Dr. Alexandre Grassart will present his groundbreaking research on mechanobiology using a gut-on-chip model, and will highlight how mastering flow control allowed to improve his organ-on-a-chip research.

“We connect the chips to the Fluigent pump system because that allows us to deliver more complex flow environments […] and visualize live on the microscope.”
Martin Knight | Professor of mechanobiology at Queen Mary university of London
Focus on the microscope. No PC required
Instead of looking at the PC, users can keep their eyes on the microscope, adjusting the control dial with one hand. In this stand-alone configuration, the device allows for pressure or flow rate control and volume dispense, making it ideal for benchtop use.

“The Fluigent microfluidics flow system has allowed us to expand our static cell models into a model of cells under flow that represents in vivo conditions more closely. Through this addition, we have been able to increase our publication output, with microfluidics at the heart of this research.
The FlowEZ allows us to manipulate flow rates quickly that allows us to introduce various activators and inhibitors to our cells, and create a system of recirculation that minimizes volume requirements, sample loss, and removes the need for users to be present for the experiment to run for hours at a time.”
Dr Cass Whelan | Research Associate, Cardiff Metropolitan University – UK
Specifications
PERFORMANCE
Resolution | 0,03% full scale |
Stability | 0,1% on the measured value (effective beyond 10% of the maximum pressure) |
Accuracy | 0,25% full scale |
Repeatability | <0.01% full scale |
Response time | Down to 30 ms |
PRESSURE/VACUUM RANGE
Part number | Pressure/Vacuum range | Required supply | Maximum pressure supply |
LU-FEZ-0025 | 0 to 25 mbar (0 to 0,36 psi) | 150 mbar (0,22 psi) | 300 mbar (4.35 psi) |
LU-FEZ-0069 | 0 to 69 mbar (0 to 1,0 psi) | 150 mbar (0,22 psi) | 300 mbar (4.35 psi) |
LU-FEZ-0345 | 0 to 345 mbar (0 to 5,00 psi) | 1100 mbar (15,95 psi) | 1300 mbar (18.85 psi) |
LU-FEZ-1000 | 0 to 1000 mbar (0 to 14,50 psi) | 1100 mbar (15,95 psi) | 1400 mbar (20.3 psi) |
LU-FEZ-2000 | 0 to 2000 mbar (0 to 29,01 psi) | 2100 mbar (30,46 psi) | 2600 mbar (37.7 psi) |
LU-FEZ-7000 | 0 to 7000 mbar (0 to 101,5 psi) | 7100 mbar (103,0 psi) | 7400 mbar (107.32 psi) |
LU-FEZ-N025 | 0 to -25 mbar (0 to -0,36 psi) | -800 mbar (-11,6 psi) | N/A |
LU-FEZ-N069 | 0 to -69 mbar (0 to -1,0 psi) | -800 mbar (-11,6 psi) | N/A |
LU-FEZ-N345 | 0 to -345 mbar (0 to -5,00 psi) | -800 mbar (-11,6 psi) | N/A |
LU-FEZ-N800 | 0 to -800 mbar (0 to -11,6 psi) | -800 mbar (-11,6 psi) | N/A |
STANDARD OPERATING CONDITIONS
Operating temperature | 20°C (68°F) |
Operating humidity | 40% HR |
HARDWARE SPECIFICATIONS
Dimensions | 91,9 x 71,8 x 131 mm (3.6 x 2.8 x 5.15 in) |
Weight | 634 g (1.4 lbs) |
ELECTRONICAL SPECIFICATIONS
Power consumption | 6 W |
CHEMICAL COMPATIBILITY
Gas compatibility | Dry, oil-free gas, air, any non corrosive or non explosive gas |
Liquid compatibility | Aqueous solvent, oil, organic solent, biological sample |
OxyGEN
Control in real-time, protocol automation, data record and export |
ver. 2.2.0.0 or more recent |
Software Development Kit
Custom software application |
ver. 22.2.0.0 or more recent |
Firmware updater

FAQ
How to determine the pressure range to choose?
Fluigent has developed a flow rate calculator to assist users in selecting the appropriate pressure range and microfluidic flow controller for their microfluidic system. They just have to provide details about their setup, including chip geometry, control type, channel and tubing dimensions. generate recommendations for flow rates and pressure ranges based on the provided data.
How can I directly control the flow rate?
Fluigent’s Flow Ez technology operates by controlling fluid flow through pressure monitoring, but the company also offers a solution for flow rate monitoring. The Flow Unit is a one-of-a-kind microfluidic flow sensor that accurately and easily monitors flow rates in any microfluidic system. An advanced thermal sensor technology provides complete media isolation and an extremely low internal volume, with no moving parts. Flow rate is then calculated based on thermal desorption, which is directly correlated with flow rate. This bidirectional microfluidic flow sensor can be used in conjunction with a microfluidic flow controller, such as the Flow Ez. To put in a nutshell, the Flow Unit is capable of measuring ultra-low liquid flow rates quickly and with exceptional precision.
Is a pressure/vacuum source needed in my setup?
The Line Up flow controllers are not equipped with an internal pressure or vacuum source, but are instead compatible with laboratory-built sources or portable pressure/vacuum generators. Fluigent provides a variety of compact pressure sources, including the Fluigent RX and FLPG Plus models, as well as a compact vacuum source. These user-friendly solutions are suitable for any flow rate and application.
How to program my experiment?
While this microfluidic flow regulator can be used independently, users also have the option of utilizing the OxyGEN software to control various parameters by simply plugging it into any computer. This software allows for real-time monitoring and automation of experiments, enabling users to create or modify time-based protocols with a variety of dedicated functions. These functions range from simple flow rate control to more complex features like conditional paths or looping. By utilizing the OxyGEN software with microfluidic flow controller and automating their experiments, users can improve the reliability and reproducibility of their results.
OEM device available
Whether you prefer to use the Flow EZ on a laboratory bench or integrate it into your own product, Fluigent has the perfect solution for your industrial development needs. Let us introduce you our F-OEM modular microfluidics flow Controller !

Expertise & resources
-
Microfluidics White Papers Double emulsion for the generation of microcapsules – a Review Read more
-
Tutorial videos Flow EZ Tutorials Episode 8: Switch it off – Fluigent Read more
-
Tutorial videos Flow EZ Tutorials Episode 7: Use the P=0 button – Fluigent Read more
-
Tutorial videos Flow EZ Tutorials Episode 6: Add my FLOW UNIT – Fluigent Read more
-
Tutorial videos Flow EZ Tutorials Episode 5: Disconnect a Flow EZ – Fluigent Read more
-
Tutorial videos Flow EZ Tutorials Episode 4 : Apply a pressure order – Fluigent Read more
-
Tutorial videos Flow EZ Tutorials Episode 3 : Add a Flow EZ – Fluigent Read more
-
Tutorial videos Flow EZ Tutorial Episode 2 : Insert in my setup – Fluigent Read more
-
Tutorial videos Flow EZ Tutorial Episode 1 : Getting started – Fluigent Read more
-
Microfluidic Application Notes Encapsulation of multiple emulsions in a single droplet Read more
-
Microfluidics Article Reviews Human Blood Brain Barrier (BBB) permeability -on-chip assessment Read more
-
Expert Reviews: Basics of Microfluidics Choosing the Right Microfluidic Pressure Range Read more
-
Fluigent Media Kit product icons & images Fluigent product icons & images Read more
-
Microfluidics White Papers An exploration of Microfluidic technology and fluid handling Read more